VCAN and neoplasm: The sulphate proteoglycan VCAN is thought to promote tumour development [21, 55] by mediating several processes such as proliferation [56–58], drug resistance [27, 56–62], cell adhesion [57–60], invasion [57, 58, 63] and angiogenesis [23, 24, 32, 33, 64, 65].